Clinical Trial Update: Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

View source ↗

Summary

Clinical trial update on riociguat for chronic thromboembolic pulmonary hypertension (CTEPH); the trial is no longer available on ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Riociguat (riociguat)

Snippet

Sponsor: Bayer | Conditions: Hypertension, Pulmonary | Status: NO_LONGER_AVAILABLE